RS

Roshitha Sasi

Active Director Additional Director DIN 09290112
DIN 09290112 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Roshitha Sasi

Data last updated:

Roshitha Sasi is an Additional Director at Le Amigo Medical Technologies Private Limited (since 2021). The company operates in Healthcare.

DIN 09290112
Primary Designation Additional Director
Industry Healthcare
First Appointment 23 Aug 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director23 Aug 20212020Active

Directorship timeline

Open interactive timeline →
Le Amigo Medical Technologies Private Limited
Premium access

Shareholding and investment profile for Roshitha Sasi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roshitha Sasi

Roshitha Sasi currently holds 1 directorship: Le Amigo Medical Technologies Private Limited (Additional Director, since 23 Aug 2021).

Roshitha Sasi was first appointed on 23 Aug 2021 as Additional Director at Le Amigo Medical Technologies Private Limited.

The current boards of Roshitha Sasi's companies include Akash Gopi (Le Amigo Medical Technologies Private Limited), Binumon (Le Amigo Medical Technologies Private Limited), Erayil Shibin (Le Amigo Medical Technologies Private Limited), Radhakrishnan Chakkiyath Narayanan Adiyodi (Le Amigo Medical Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available